Medifast, Inc. (MED)
Pre-market:
| Previous close | 22.83 |
| Open | 22.99 |
| Bid | 22.01 x 900 |
| Ask | 0.00 x 900 |
| Day's range | 22.70 - 24.94 |
| 52-week range | 22.35 - 109.52 |
| Volume | |
| Avg. volume | 455,598 |
| Market cap | 271.243M |
| Beta (5Y monthly) | 1.21 |
| PE ratio (TTM) | 3.69 |
| EPS (TTM) | 6.72 |
| Earnings date | 05 Aug 2024 - 09 Aug 2024 |
| Forward dividend & yield | 6.60 (28.91%) |
| Ex-dividend date | 18 Sept 2023 |
| 1y target est | 25.00 |
StockStoryQ1 Earnings Outperformers: Olaplex (NASDAQ:OLPX) And The Rest Of The Personal Care Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q1 now behind us, let’s have a look at Olaplex (NASDAQ:OLPX) and its peers.
Simply Wall St.Investors Could Be Concerned With Medifast's (NYSE:MED) Returns On Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Business WireMedifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
BALTIMORE, May 20, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering in collaboration with LifeMD®, the GLP-1 Lifestyle Program, a holistic approach to medical weight loss specifically tailored to support the needs of those utilizing GLP-1 medications. This robust
